Top-News

Bioage Labs Aktie News

Aktie
WKN:  A40D7P ISIN:  US09077V1008 US-Symbol:  BIOA Branche:  Pharmazeutika Land:  USA
10,10 €
+0,15 €
+1,51%
07:30:32 Uhr
Depot/Watchlist
Marktkapitalisierung *
240,68 Mio. €
Streubesitz
27,79%
KGV
-2,92
Index-Zuordnung
-

Bioage Labs News

28.02.25 - PR Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in BioAge Lawsuit - BIOA
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in BioAge Lawsuit - BIOA PR Newswire
27.02.25 - PR Newswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs PR Newswire
27.02.25 - PR Newswire
Investors in BioAge Labs, Inc. Should Contact The Gross Law Firm Before March 10, 2025 to Discuss Your Rights - BIOA
Investors in BioAge Labs, Inc. Should Contact The Gross Law Firm Before March 10, 2025 to Discuss Your Rights - BIOA PR Newswire
26.02.25 - PR Newswire
BioAge Labs, Inc. (BIOA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
BioAge Labs, Inc. (BIOA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
25.02.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in BioAge Labs, Inc. of Class Action Lawsuit and Upcoming Deadlines - BIOA
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in BioAge Labs, Inc. of Class Action Lawsuit and Upcoming Deadlines - BIOA PR ...
25.02.25 - PR Newswire
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
25.02.25 - PR Newswire
Class Action Filed Against BioAge Labs, Inc. (BIOA) Seeking Recovery for Investors - Contact Levi & Korsinsky
Class Action Filed Against BioAge Labs, Inc. (BIOA) Seeking Recovery for Investors - Contact Levi & Korsinsky PR Newswire
24.02.25 - PR Newswire
The Gross Law Firm Notifies Shareholders of BioAge Labs, Inc.(BIOA) of a Class Action Lawsuit and an Upcoming Deadline
The Gross Law Firm Notifies Shareholders of BioAge Labs, Inc.(BIOA) of a Class Action Lawsuit and an Upcoming Deadline PR Newswire
23.02.25 - PR Newswire
BIOA Deadline: BIOA Investors with Losses in Excess of $100K Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit
BIOA Deadline: BIOA Investors with Losses in Excess of $100K Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit PR Newswire
22.02.25 - PR Newswire
BioAge Labs, Inc. Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit
BioAge Labs, Inc. Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit PR ...
21.02.25 - PR Newswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc.(BIOA) Shareholders
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc.(BIOA) Shareholders PR Newswire
20.02.25 - PR Newswire
BioAge Labs, Inc. (BIOA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
BioAge Labs, Inc. (BIOA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
20.02.25 - PR Newswire
Faruqi & Faruqi Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA
Faruqi & Faruqi Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA PR Newswire
20.02.25 - PR Newswire
Shareholders that lost money on BioAge Labs, Inc.(BIOA) should contact The Gross Law Firm about pending Class Action - BIOA
Shareholders that lost money on BioAge Labs, Inc.(BIOA) should contact The Gross Law Firm about pending Class Action - BIOA PR Newswire
18.02.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in BioAge Labs, Inc. of Class Action Lawsuit and Upcoming Deadlines - BIOA
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in BioAge Labs, Inc. of Class Action Lawsuit and Upcoming Deadlines - BIOA PR ...
18.02.25 - PR Newswire
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit PR Newswire
18.02.25 - PR Newswire
BioAge Labs, Inc. (BIOA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
BioAge Labs, Inc. (BIOA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
18.02.25 - PR Newswire
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
18.02.25 - PR Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in BioAge Lawsuit - BIOA
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in BioAge Lawsuit - BIOA PR Newswire
16.02.25 - PR Newswire
BioAge Labs, Inc. (BIOA) Investors: March 10, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
BioAge Labs, Inc. (BIOA) Investors: March 10, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP PR Newswire

Newssuche

Videos

newspaper
06.12.25
Master the Trading!
In diesem Trading-​Webinar haben wir von A bis Z den Aufbau professionellen Tradings thematisiert und ... Mehr »
Anzeige

Aktie im Fokus

Breaking News
TempraMed Technologies Ltd
0,3605 €
0,00%
TempraMed Technologies Ltd Chart
Das 1.000% Wachstum initiiert?!
Mehr zur Aktie »